Custom Design of Non-Canonical tRNA/Synthetase Systems

inquiry

The integration of unnatural amino acids (uAAs) into proteins requires translation components that can accurately recognize, charge, and incorporate chemical structures not found in nature. Creative Enzymes provides comprehensive custom engineering of non-canonical tRNA and aminoacyl-tRNA synthetase (aaRS) systems designed to work orthogonally within a host organism. By tailoring the anticodon loop, identity elements, structural domains, and catalytic pocket residues, we generate tRNA/aaRS pairs that enable precise decoding of predefined codons and highly selective recognition of user-specified uAAs. Our service supports applications ranging from molecular imaging and mechanistic dissection to therapeutic protein development, structural mapping, and bioorthogonal conjugation strategies.

Background on Non-Canonical tRNA/Synthetase Systems

Limitations of the Native Genetic Code

The natural genetic code restricts protein synthesis to twenty canonical amino acids, limiting the chemical diversity and functional repertoire of proteins. To expand this molecular toolkit, researchers rely on orthogonal translation systems capable of introducing new monomers into the proteome without interfering with endogenous biology.

Orthogonal tRNA/aaRS Systems: A Cornerstone of Genetic Code Expansion

Orthogonal translation components bypass native aminoacylation pathways, typically by:

Decoding reassigned stop codons (e.g., amber, opal),
Reading expanded codons (e.g., quadruplet codons), or
Synthesizing entirely synthetic ribosomal circuits in specialized systems.

The accuracy and efficiency of these engineered systems depend on extremely high substrate specificity, orthogonality to native machinery, and sufficient expression stoichiometry. Custom-designed tRNA and aaRS variants are especially critical when incorporating large, sterically hindered, reactive, or chemically novel uAAs.

Noncanonical amino acid incorporation in animals and animal cells Figure 1. Components of genetic code expansion. An orthogonal AARS/tRNA pair is designed to avoid cross-reactivity with endogenous AARSs and tRNAs. (b) ncAAs can be inserted at a designed position by employing a tRNA with a complementary anticodon to the target nonsense codon. (Kim et al., 2024)

Challenges Requiring Expert Engineering

Developing a fully functional non-canonical tRNA/aaRS pair requires addressing:

Substrate discrimination between the target uAA and structurally similar natural amino acids
Catalytic compatibility of uAA charging
Structural stability of the engineered tRNA
Balance of tRNA abundance and aaRS expression levels
Host-specific performance variations (e.g., tRNA processing in eukaryotes vs. bacteria)
Suppression efficiency and translational fidelity under different culture conditions

Creative Enzymes provides specialized expertise to overcome these complexities through computational design, molecular evolution, and rigorous validation strategies.

What We Offer

At Creative Enzymes, we deliver comprehensive, custom-engineered non-canonical tRNA and aminoacyl-tRNA synthetase (aaRS) systems, tailored to your enzyme engineering needs. Our services include:

Services		Price
Tailored Orthogonal tRNA Design	We construct custom tRNA molecules optimized for decoding reassigned codons with: Modified anticodon loops for stop-codon or quadruplet decoding Redesigned D- and T-arm structures for improved folding and ribosomal compatibility tRNA identity element rewiring to prevent mischarging by endogenous aaRSs Host-specific promoter and processing element engineering for stable expression	Get a quote
Customized Aminoacyl-tRNA Synthetase Engineering	Our engineering focuses on creating aaRS variants that selectively recognize and charge the target uAA by: Remodeling active-site residues Reshaping the substrate binding cavity Engineering loops and editing domains Using computational docking to predict optimal interactions Applying directed evolution to screen thousands of variants Eliminating background charging and reducing natural amino acid promiscuity
Engineering for Unusual Chemical Functionalities	We routinely engineer systems for uAAs containing: Photo-reactive groups (diazirines, benzophenones) Bioorthogonal handles (azides, alkynes, strained alkenes) Heavy atoms (iodine, selenium) for structural studies Post-translational mimicry (phosphoserine, sulfotyrosine analogs) Metal-binding ligands Fluorogenic and solvatochromic dyes
Host-Specific Optimization	We tailor the system to the biology of each platform: E. coli: optimized orthogonality, high suppression efficiency Yeast: tRNA processing compatibility and enhanced stability Mammalian cells: codon optimization, nuclear export signals, and reduced cytotoxicity Cell-free systems: tunable concentrations and maximized incorporation fidelity
Rigorous Screening and Selection	We employ advanced selection technologies including: Dual positive/negative selection scaffolds Small-molecule responsive survival assays High-throughput sequencing of variant pools Mass spectrometry–driven functional verification
Delivery of Fully Validated Systems	Each project culminates in the delivery of: Custom-designed tRNA expression cassettes Evolved and validated aaRS constructs Complete sequence information and analytical data Recommended expression protocols Incorporation efficiency and fidelity reports

Service Workflow

Service workflow of custom design of non-canonical tRNA/synthetase systems

Contact Our Team

Why Choose Us

Exceptional Precision Through Multi-Layered Engineering

We combine structural modeling, evolutionary analysis, and experimental screening to ensure stringent substrate specificity and minimal background charging.

Proven Success Across Diverse Chemical Classes

From bulky hydrophobic uAAs to reactive conjugation handles, we have demonstrated compatibility with hundreds of chemical structures.

Expertise Across All Major Expression Platforms

Our systems are optimized for bacterial, fungal, mammalian, and cell-free hosts, enabling smooth transition from discovery to production.

High-Throughput Evolution and Screening Platforms

Automated positive/negative selection pipelines allow rapid identification of top-performing tRNA/aaRS variants.

Comprehensive End-to-End Support

We guide clients from conceptual design to downstream protein purification, labeling, and mechanistic characterization.

Guaranteed Quality and Reproducibility

All constructs undergo full validation, and every system is benchmarked to ensure reliable, high-fidelity incorporation.

Case Studies and Success Stories

Case 1: Engineering a Diazirine-Compatible aaRS for Photocrosslinking

Client Need:

A structural biology research team required a reliable method for incorporating a diazirine-containing photoreactive unnatural amino acid into a specific position within an enzyme active site.

Our Approach:

We began by designing an aminoacyl-tRNA synthetase featuring an expanded substrate-binding channel capable of accommodating the bulky diazirine moiety. Through iterative rounds of mutagenesis and functional screening, we enhanced the catalytic turnover of the synthetase while retaining strict discrimination against natural amino acids. In parallel, we refined the folding and stability of the paired orthogonal tRNA to optimize amber suppression under the client's expression conditions. The full system—synthetase, tRNA, and expression construct—was validated through analytical assays to ensure high specificity for the target diazirine-uAA.

Outcome:

The engineered system achieved a six-fold improvement in suppression efficiency, with incorporation fidelity exceeding 95%. Using the resulting enzyme variant, the client successfully mapped a set of transient, previously undetectable interaction states through UV-triggered photocrosslinking, significantly advancing their mechanistic model of protein complex formation.

Case 2: Mammalian Expression System for Bioorthogonal Conjugation

Client Need:

A biopharmaceutical company developing next-generation antibody–drug conjugates needed a mammalian expression platform capable of reliably incorporating azide-functionalized amino acids. Their internal systems lacked the stability and fidelity required for large-scale CHO cell production, leading to inconsistent conjugation efficiency during process development.

Our Approach:

We delivered a fully human-optimized orthogonal tRNA/aaRS pair designed for robust performance in mammalian cells. The system incorporated engineered sequence elements that enhance nuclear export, maintain stable cytoplasmic expression, and support efficient aminoacylation under high-density CHO culture conditions. To ensure chemical purity at the incorporation site, we applied negative-selection strategies to minimize off-target charging and verified system performance through mass spectrometry and functional assays.

Outcome:

The optimized platform produced high, consistent protein yields in CHO cells while maintaining excellent specificity for the azide-bearing ncAA. The expressed antibodies achieved uniform, high-efficiency click-chemistry conjugation, enabling the client to advance their ADC program with significantly improved process reliability and product homogeneity.

Frequently Asked Questions

Q: Can you design systems for completely novel unnatural amino acids?

A: Yes—if you can provide structural details or even a rough chemical concept, we can engineer aaRS active sites tailored to brand-new uAAs. We routinely model binding pockets, predict compatibility, and validate performance experimentally to ensure reliable incorporation.
Q: How long does a typical project take?

A: Timelines vary with complexity. Straightforward tRNA optimization or amino acid swapping may be completed within a few weeks. More elaborate projects—such as directed evolution of a new aaRS or multi-site incorporation workflows—may take several months, especially if iterative rounds of screening are required.
Q: Do you assist with downstream protein expression and characterization?

A: Absolutely. We can handle expression trials, purification, labeling validation, and functional assays. For trickier targets, we can also advise on expression formats, codon context effects, and folding conditions to maximize incorporation fidelity.
Q: Which codon strategies do you support?

A: We provide systems for amber suppression, opal/ochre suppression, quadruplet decoding, recoded strain integration, and even custom reassigned codons for expanded genetic-code architectures. If you're exploring exotic decoding schemes, we're usually game.
Q: Will the engineered system interfere with native translation?

A: No. All our tRNA/aaRS pairs undergo orthogonality testing to ensure they don't cross-react with endogenous host machinery. We also evaluate potential impacts on global translation efficiency, cell health, and growth rates.
Q: Can you support multi-site incorporation of unnatural amino acids?

A: Yes. We can design systems capable of installing two or more distinct uAAs in a single protein—either via multiple suppressor tRNAs, engineered quadruplet systems, or combinations of engineered synthetases.
Q: What host organisms do you support?

A: Our platforms cover E. coli, yeast, insect cells, CHO and HEK cells, and a variety of recoded or specialized strains. If you have a niche organism in mind, we can usually adapt our toolkit.

Reference:

Kim JC, Kim Y, Cho S, Park HS. Noncanonical amino acid incorporation in animals and animal cells. Chem Rev. 2024;124(22):12463-12497. doi:10.1021/acs.chemrev.3c00955

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry